Molecular Templates, Inc.

Molecular Templates, Inc. (MTEM) is a clinical stage biopharmaceutical company focused on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform with unique mechanisms of actions which are highly differentiated from antibody drug conjugates (ADCs). MTEM is developing MT-6402, which is in a Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients; MT-5111, which is in a Phase I clinical trial for the treatment of HER2-positive cancers; and MT-0169, which is in a Phase I clinical trial to treat relapsed/refractory myeloma. Additional preclinical compounds derived from our ETB platform technology are being advanced toward clinical development. Additional information about MTEM can be obtained at www.mtem.com.

9301 Amberglen Blvd, Ste 100
Austin, TX 78729

Tel: 512-869-1555

Visit website

Email Us

Stock Symbol: MTEM
Stock Exchange: NASDAQ

NEWS

Business

Molecular Templates Forges Cancer Deal with BMS Worth up to $1.3 Billion

Eric Poma, chief executive and scientific officer for Molecular Templates, touted the partnership with BMS and its strong oncology franchise.

February 12, 2021

2 min read

Alex Keown

BioCapital

Clinical Catch-Up: February 17-21

Mid-February had a solid number of clinical trial announcements. Here’s a look.

February 21, 2020

6 min read

Mark Terry

Job Trends

Clinical Catch-Up: December 9-13

It was a particularly busy week in clinical trial news, largely because of the American Society of Hematology Annual Meeting. Here’s a look.

December 13, 2019

13 min read

Mark Terry

Drug Development

ASH Roundup: Bristol-Myers Squibb, bluebird bio, Oryzon and More

As the 61st American Society of Hematology Annual Meeting wrapped up in Orlando, Florida, there were hundreds of studies and results presented. Here’s a look at some.

December 10, 2019

3 min read

Mark Terry

Job Trends

Molecular Templates to Present at Two December 2019 Investor Conferences

Molecular Templates, Inc. announced that Eric Poma, Ph.D., Chief Executive Officer and Chief Scientific Officer, will present a corporate overview at the Evercore ISI HealthCONx Conference, and the Piper Jaffray 31st Annual Healthcare Conference.

November 27, 2019

1 min read

Employer Resources

Top 10 Cities in the U.S. for the Job Market

New Year, fresh start? Could be. WalletHub recently compared more than 180 cities across the U.S., using 30 key indicators to evaluate their job strength. Some of those factors were job opportunities, employment growth, monthly average starting salary and employment outlook.

January 14, 2019

3 min read

Mark Terry

Business

Molecular Templates and Takeda to Take on Multiple Myeloma in Deal Worth up to $632 Million

Shares of Molecular Templates are up more than 52 percent in premarket trading after the company announced it has struck a deal with pharma giant Takeda Pharmaceuticals.

September 20, 2018

2 min read

Alex Keown